Interdisciplinary Care Model: Chronic Kidney Disease and Oral Health

  • Ingrid Glurich
  • Neel Shimpi
  • Amit AcharyaEmail author
Part of the Health Informatics book series (HI)


Global prevalence of chronic kidney disease (CKD) has increased significantly, along with the annual death rate due to CKD and the associated high cost of treatment. Oral and maxillofacial impact is noted in the context of CKD. This chapter provides an overview of the oral and renal association and mechanisms through which oral disease contributes to CKD risk. Authors also present technological implications and various risk assessment tools that can be used in clinical practice. Further, the chapter highlights the advancing potential for translation of precision medicine approaches to the clinical arena to optimize CKD management across the disease spectrum to improve CKD detection and outcomes. Finally, the chapter identifies important gaps in clinical practice guidelines with respect to advancing integrated dental-medical care delivery due to absence of emphasis on potential oral-renal interactions which have been demonstrated and validated in the evidence base by systematic review.


Chronic renal insufficiency Periodontitis Integrated health care delivery Electronic health record Clinical decision support systems 


  1. Abe D, Kubota T, Morozumi T, Shimizu T, Nakasone N, Itagaki M, Yoshie H. Altered gene expression in leukocyte transendothelial migration and cell communication pathways in periodontitis-affected gingival tissues. J Periodontal Res. 2011;46(3):345–53. Scholar
  2. Araújo M, Hong B, Fava P, Khan S, Burleson J, Fares G, et al. End stage renal disease as a modifier of the periodontal microbiome. BMC Nephrol. 2015;16(1):80. Scholar
  3. Artese H, Sousa C, Torres M, Silva-Boghossian C, Colombo A. Effect of non-surgical periodontal treatment on the subgingival microbiota of patients with chronic kidney disease. Braz Oral Res. 2012;26(4):366–72. Scholar
  4. Atzler D, Schwedhelm E, Zeller T. Integrated genomics and metalomics in nephrology. Nephrol Dial Transplant. 2014;29:1467–74. Scholar
  5. Centers for Disease Control and Prevention. Chronic kidney disease (CKD) surveillance project. 2018. Accessed 10 June 2018.
  6. Centers for Disease Control and Prevention. Chronic kidney disease basics. Chronic kidney disease initiative. CDC. 2017. Accessed 30 Aug 2018.
  7. Chen Z, Zhang X, Zhang Z. Clinical risk assessment of patients with chronic kidney disease by using clinical data and multivariate models. Int Urol Nephrol. 2016;48(12):2069–75. Scholar
  8. Cisek K, Krochmal M, Klein J, Mischak H. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease. Nephrol Dial Transplant. 2016;31(12):2003–11. Scholar
  9. Cole N, Liyanage H, Suckling R, Swift P, Gallagher H, Byford R, et al. An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study. BMC Nephrol. 2018;19(1):85. Scholar
  10. Corredor Z, Stoyanova E, Rodriguez-Ribera L, Coll E, Silva I, Diaz J, et al. Genomic damage as a biomarker of chronic kidney disease status. Environ Mol Mutagen. 2015;56:301–12. Scholar
  11. Davanian H, Stranneheim H, Båge T, Lagervall M, Jansson L, Lundeberg J, Yucel-Lindberg T. Gene expression profiles in paired gingival biopsies from periodontitis-affected and healthy tissues revealed by massively parallel sequencing. PLoS One. 2012;7(9):e46440. Scholar
  12. Davison S, Levin A, Moss AH, Jha V, Brown E, Brennan F, et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int. 2015;88(3):447–59. Scholar
  13. Drawz P, Archdeacon P, McDonald C, Powe N, Smith K, Norton J, et al. CKD as a model for improving chronic disease care through electronic health records. Clin J Am Soc Nephrol. 2015;10(8):1488–99. Scholar
  14. Eke P, Dye B, Wei L, Slade G, Thornton-Evans G, Borgnakke W, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86(5):611–22. Scholar
  15. Fricke W, Maddox C, Song Y, Bromberg J. Human microbiota characterization in the course of renal transplantation. Am J Transplant. 2014;14(2):416–27. Scholar
  16. Gheewala P, Peterson G, Zaidi S, Jose M, Castelino R. Evaluation of a chronic kidney disease risk assessment service in community pharmacies. Nephrology. 2018a;
  17. Gheewala P, Peterson G, Zaidi S, Jose M, Castelino R. Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study. BMC Public Health. 2018b;18(1):371. Scholar
  18. Glassock R, Warnock D, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–14. Scholar
  19. Hill N, Fatoba S, Oke J, Hirst J, O’Callaghan C, Lasserson D, Hobbs F. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. Scholar
  20. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. Scholar
  21. Jolly S, Navaneethan S, Schold J, Arrigain S, Konig V, Burrucker YK, et al. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015;16(1):69. Scholar
  22. KDIGO Workgroup. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.Google Scholar
  23. KDIGO. Guidelines. KDIGO; 2018. Accessed 9 June 2018.
  24. Kebschull M, Demmer R, Grün B, Guarnieri P, Pavlidis P, Papapanou PN. Gingival tissue transcriptomes identify distinct periodontitis phenotypes. J Dent Res. 2014;93(5):459–68. Scholar
  25. König J, Holtfreter B, Kocher T. Periodontal health in Europe: future trends based on treatment needs and the provision of periodontal services - position paper 1. Eur J Dent Educ. 2010;14:4–24. Scholar
  26. Kornman K, Crane A, Wang H, di Giovine F, Newman M, Pirk F, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997;24(1):72–7. Scholar
  27. Köttgen A, Hwang S-J, Larson MG, Van Eyk JE, Fu Q, Benjamin EJ, et al. Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol. 2010a;21(2):337–44. Scholar
  28. Köttgen A, Pattaro C, Böger C, Fuchsberger C, Olden M, Glazer N, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010b;42(5):376–84. Scholar
  29. Lee C, Lin C, Lin M, Lin S, Sung F, Kao C. Surgical treatment for patients with periodontal disease reduces risk of end-stage renal disease: a nationwide population-based retrospective cohort study. J Periodontol. 2014;85(1):50–6. Scholar
  30. Levey A, Coresh J, Balk E, Kausz A, Levin A, Steffes M, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47. Scholar
  31. Macedo Paizan M, Vilela-Martin J. Is there an association between periodontitis and hypertension? Curr Cardiol Rev. 2014;10(4):355–61. Scholar
  32. National Kidney Foundation. Global facts: about kidney disease. National Kidney Foundation; 2015. Accessed 9 June 2018.
  33. National Kidney Foundation. Global facts: about kidney disease. 2017. Accessed 30 Aug 2018.
  34. Navaneethan S, Schold J, Kirwan J, Arrigain S, Jolly S, Poggio ED, et al. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013;8(6):945–52. Scholar
  35. NIDDK. Kidney disease statistics for the United States. NIDDK; 2018. Accessed 9 June 2018.
  36. Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés À, Lundin U, Weinberger K, et al. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. PLoS One. 2014;9(5):e96955. Scholar
  37. Ott SM, Elder G. Osteoporosis associated with chronic kidney disease. In: Osteoporosis. Amsterdan: Elsevier; 2013. p. 1387–424. Scholar
  38. Oyetola E, Owotade F, Agbelusi G, Fatusi O, Sanusi A. Oral findings in chronic kidney disease: implications for management in developing countries. BMC Oral Health. 2015;15(1):24. Scholar
  39. Pattaro C, Köttgen A, Teumer A, Garnaas M, Böger C, Fuchsberger C, et al. Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet. 2012;8(3):e1002584. Scholar
  40. Petersen P, Ogawa H. The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000. 2012;60(1):15–39. Scholar
  41. Pontes F, Lopes M, de Souza L, dos Santos da Mata Rezende D, Santos-Silva A, Jorge J, et al. Oral and maxillofacial manifestations of chronic kidney disease–mineral and bone disorder: a multicenter retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(1):31–43. Scholar
  42. Pontillo C, Zhang Z, Schanstra J, Jacobs L, Zürbig P, Thijs L, et al. Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker. Kidney Int Rep. 2017;2(6):1066–75. Scholar
  43. Ruospo M, Palmer S, Craig J, Gentile G, Johnson D, Ford P, et al. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant. 2014;29(2):364–75. Scholar
  44. Sagliker Y, Balal M, Sagliker Ozkaynak P, Paydas S, Sagliker C, Sabit Sagliker H, et al. Sagliker syndrome: uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure. Semin Nephrol. 2004;24(5):449–55. Scholar
  45. Saran R, Hedgeman E, Plantinga L, Burrows N, Gillespie B, Young E, et al. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol. 2010;5(1):152–61. Scholar
  46. Schena F. Biomarkers and personalized therapy in chronic kidney diseases. Expert Opin Investig Drugs. 2014;23(8):1051–4. Scholar
  47. Smiley C, Tracy S, Abt E, Michalowicz B, John M, Gunsolley J, et al. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015;146(7):525–35. Scholar
  48. Teumer A, Holtfreter B, Völker U, Petersmann A, Nauck M, Biffar R, et al. Genome-wide association study of chronic periodontitis in a general German population. J Clin Periodontol. 2013;40(11):977–85. Scholar
  49. Trindade F, Oppenheim F, Helmerhorst E, Amado F, Gomes PS, Vitorino R. Uncovering the molecular networks in periodontitis. Proteomics Clin Appl. 2014;8(9–10):748–61. Scholar
  50. Tsakos G, Sabbah W, Hingorani A, Netuveli G, Donos N, Watt R, DʼAiuto F. Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey. J Hypertens. 2010;28(12):1. Scholar
  51. Xu P, Gunsolley J. Application of metagenomics in understanding oral health and disease. Virulence. 2014;5(3):424–32. Scholar
  52. Xu S, Song M, Xiong Y, Liu X, He Y, Qin Z. The association between periodontal disease and the risk of myocardial infarction: a pooled analysis of observational studies. BMC Cardiovasc Disord. 2017;17(1):50. Scholar
  53. Yang W, Jia Y, Wu H. Four tumor necrosis factor alpha genes polymorphisms and periodontitis risk in a Chinese population. Hum Immunol. 2013;74(12):1684–7. Scholar
  54. Zhang J, Jiang H, Sun M, Chen J. Association between periodontal disease and mortality in people with CKD: a meta-analysis of cohort studies. BMC Nephrol. 2017;18(1):269. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Center for Oral and Systemic HealthMarshfield Clinic Research InstituteMarshfieldUSA

Personalised recommendations